Drug Topics August 28, 2023
Killian Meara

A recent study found that there was a lack of strong evidence supporting the use of continuous glucose monitor programs in community pharmacies.

The implementation of continuous glucose monitor services that are led by pharmacists could have a beneficial impact in the ambulatory care setting, according to new research published in the Journal of the American Pharmacists Association.1

Continuous glucose monitors have been available for over 20 years and are known to improve clinical endpoints for patients with diabetes, including hemoglobin A1c and time in the target glycemic range. Despite these known benefits, their use remains low in clinical settings and uptake among patients is poor.

As trusted health care professionals, pharmacists in both the community and ambulatory care settings...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Survey / Study, Technology, Trends, Wearables
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article